Recent

% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • nndung802000 nndung802000 Dec 14, 2012 5:09 PM Flag

    Emerging Agents for treatment of Ovarian Cancer

    Ovarian cancer is the second most common gynecologic cancer and the deadliest in terms of absolute figure. It caused nearly 14,000 deaths in the United States alone in 2010. Global ovarian cancer drugs market to reach $2,352 million.

 
EXEL
5.64+0.08(+1.44%)Sep 4 3:59 PMEDT